Cargando…
Non-clinical assessment design of autologous chondrocyte implantation products
The aims of this study were to investigate the premarket assessment of autologous chondrocyte implantation (ACI) products especially regarding the non-clinical assessment by surveying the guidelines and review reports of authorized ACI products in detail and to provide information regarding the non-...
Autores principales: | Ikawa, Taisuke, Yano, Kazuo, Watanabe, Natsumi, Masamune, Ken, Yamato, Masayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581806/ https://www.ncbi.nlm.nih.gov/pubmed/31245449 http://dx.doi.org/10.1016/j.reth.2015.06.003 |
Ejemplares similares
-
Regulatory approval for autologous human cells and tissue products in the United States, the European Union, and Japan
por: Yano, Kazuo, et al.
Publicado: (2014) -
Bayesian statistics and clinical trial designs for human cells and tissue products for regulatory approval
por: Jokura, Yoji, et al.
Publicado: (2016) -
Expedited approval system for regenerative medicine products – Is it unusual?
por: Yano, Kazuo, et al.
Publicado: (2016) -
PRP therapy classification
por: Yamato, Masayuki, et al.
Publicado: (2015) -
Re-examination of regulatory opinions in Europe: possible contribution for the approval of the first gene therapy product Glybera
por: Watanabe, Natsumi, et al.
Publicado: (2015)